Hempstract, Inc.

Hempstract, Inc.

HPST
Hempstract, Inc.US flagOther OTC
0.03
USD
+0.00
- -
25.55MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Ronald M. Herzfeld
Full Time Employees
2
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
PO Box 665 Warden WA United States of America 98857-0665
IPO Date
Jan 8, 2021
Business
Hempstract, Inc. Hempstract, Inc. (HPST) produces and sells cannabidiol (CBD) and cannabigerol solutions principally in the United States; its core products include CBD isolate powder, distillate oil, and nutritional whole plant extracts formulated for topicals, lotions, bath bombs, pills, and pet products derived from non-GMO industrial hemp using THC-free processes. The company, formerly known as Riverdale Oil and Gas Corporation until its name change in November 2020 following a strategic pivot from oil and gas operations, maintains headquarters in Warden, Washington, with additional addresses listed in Seattle, Washington, and Huntington Beach, California. Hempstract, Inc. targets business partners such as grocery chains, convenience stores, and PPE supply chains through premium CBD solutions and white label services, while operating laboratories focused on isolating novel cannabinoids and developing new formulations; in 2020, it completed a major asset acquisition from Hempstract, LLC, valued at over $11 million including 3,125 kilograms of CBD isolate, issued over 36 million shares for the transaction, and renovated a historic ICBM Titan Missile facility site in eastern Washington for high-quality production.

Company News

APIChat
  • Justin Costello Steps Down as Chairman of Hempstract Inc.

  • Hempstract Inc. Completes Financial Forecasts for Tolling Agreements.

  • Hempstract Inc. Completes First Round of CBD Extraction